INDEMNIFICATION AGREEMENTIndemnification Agreement • April 21st, 2017 • Argenx N.V • Biological products, (no disgnostic substances)
SERVICE AGREEMENT between Bio-Incubator Gent 2 NV and argenx bvbaAgreement • April 21st, 2017 • Argenx N.V • Biological products, (no disgnostic substances)
The Service Provider and the Service Receiver are hereinafter referred to jointly as the “Parties” and individually also as a “Party”.
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[...***...].” A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE U.S. SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION...Patent License Agreement • April 21st, 2017 • Argenx N.V • Biological products, (no disgnostic substances) • Texas
This Patent License Agreement (“Agreement”) is between The Board of Regents of The University of Texas System, an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas Southwestern Medical Center, a component institution of The University of Texas System (“Licensor”) and arGEN-X BV, a Dutch corporation, with its principal place of business at Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands (“Licensee”) (collectively, “Parties”, or singly, “Party”).
